Skip to main content
SpringerLink
Log in

Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis

  • Correspondence
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Noda R, Kawashima M, Segawa M, Tsunoda S, Inoue T, Akabane A. Fractionated versus staged gamma knife radiosurgery for mid-to-large brain metastases: a propensity score-matched analysis. J Neurooncol. 2023;164(1):87–96.

  2. van Schie P, Rijksen BLT, Bot M, Wiersma T, Merckel LG, Brandsma D, et al. Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series. J Neurooncol. 2023;163(2):345 − 54.

  3. Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, et al. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient. J Clin Oncol. 2020;38(32):3773-84.

Download references

Author information

Authors and Affiliations

  1. Division of Cancer Sciences, School of Medical Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health & Manchester Cancer Research Centre, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester, UK

    G. R. Borst

  2. Departments of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK

    G. R. Borst

  3. Department of Neurosurgery, Cancer Center Amsterdam (CCA), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands

    R. Post

  4. Department of Radiation Oncology, Cancer Institute – Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands

    R. Post

Authors
  1. G. R. Borst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Post
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

G.B. and R.P. wrote the correspondence.

Corresponding author

Correspondence to G. R. Borst.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Borst, G.R., Post, R. Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis. J Neurooncol 164, 757–758 (2023). https://doi.org/10.1007/s11060-023-04457-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-023-04457-6

Search

Navigation